Project to Cure AgingOctober 2016
By William Faloon
Microsoft may be the most successful business to ever exist.
Bill Gates is credited with Microsoft’s success. Less known is a person behind much of Microsoft’s meteoric growth after Gates relinquished operational control.
His name is Steve Ballmer and his performance at Microsoft is unmatched by a number of financial precedents.
Est. Net Worth: $25 Billion
Microsoft CEO (2000-2014)
Graduate: Harvard University
Despite Ballmer’s achievements, he was not without flaws. He dismissed what would become the world’s most popular product (the iPhone) because of its cost and lack of keyboard. After its launch in 2007 Ballmer famously said:
“There’s no chance that the iPhone is going to get any significant market share.”
Ballmer was not alone. Many in Silicon Valley predicted the iPhone could not work from a technical standpoint and if it did, it would fail in the marketplace.
Contrary to expert opinion, the iPhone became the most sought after consumer product of all time. The maker of the iPhone (Apple) grew to become one of the most valuable companies on Earth.
In describing a premise behind the iPhone concept, Steve Jobs famously said:
“A lot of times, people don’t know what they want until you show it to them.”
So what does all this have to do with curing aging?
First off, most medical “experts” don’t think it can be done. In addition, much of the public questions whether they want to see aging vanquished.
None of this cynicism is deterring the Life Extension Foundation® from pursuing research aimed at inducing meaningful and systemic reversal of biological aging processes.
From a humanitarian standpoint, control over degenerative aging will represent a biomedical renaissance. For those interested in monetary gain, the potential in discovering ways to reverse biological aging may be substantial.
This article describes how Life Extension Foundation and others have joined to launch a new company called Age Reversal Therapeutics, Inc.
The Aging Cure Company
Age Reversal Therapeutics, Inc. has been established to rapidly transform already developed medical technologies into the human clinical arena.
Our objective is to leave no scientist unfunded whose technology is far enough advanced to safely test in senescent individuals, many of whom have volunteered to participate in this unprecedented endeavor.
The initial goal of Age Reversal Therapeutics, Inc., is to fill missing biological gaps that confine humans to frustratingly short lifespans. Even modest success may enable people today to regain some of their lost functional vitality.
A key objective of Age Reversal Therapeutics is to engineer cellular DNA so there will be no upper-limit threshold whereby maturing humans will be deprived of youthful health and well-being.
Much of the public erroneously thinks that innovations enjoyed today would have eventually been developed because the technology was “obvious.”
Even a cursory historic review reveals how flawed this naïve supposition is. The reality is that most areas of discovery initiate, stop, start, and go backwards again until the technology advances sufficiently to gain widespread acceptance.
Delays happen because of physical limitations, inability of inventors to persevere, and oppression by whatever “authority” of their day existed.
“Without Einstein, We Would All Be Lost”
We take for granted modern conveniences that could not exist if Albert Einstein’s mastery of the physical universe had been repressed.
Most people view GPS (global positioning navigation) as something that would have been invented by someone because the benefits are so apparent. Yet without Einstein’s theory of relativity, GPS devices would not function.
To appreciate this, GPS requires rapid communication with orbiting satellites that measure time in a few billionths of a second. Without Einstein’s relativity theory, “we would all be lost” according to a Wall Street Journal article commemorating Einstein’s contributions to modern innovation that Einstein himself could not have predicted.
Einstein’s theories were not initially greeted with wild enthusiasm. Skeptics and critics abounded, and the general public perceived little value in Einstein’s mathematical measurements of time and space.
A century after Einstein’s initial discoveries, mankind continues to gather valuable apples from the scientific trees he planted.
But what if Einstein had been born a few decades later? His likely fate would have been death in a Nazi concentration camp. Einstein’s early work was done in Germany before he migrated to the United States to escape religious persecution.
As mentioned in the beginning of this article, “authorities” exert tremendous influence over the velocity of innovation.
We Already Know a Lot About Biological Aging
When I incorporated Life Extension Foundation in 1977, theories about how we age were in a primitive state. So much so that we did not attract our first contributor until 1980 when Saul Kent started a publication called Anti-Aging News.
Back then, some people were interested in reading about ways to possibly slow aging. Few wanted to contribute to research because, quite frankly, there was insufficient knowledge to expect an advance in the laboratory would transform into clinical reality.
As decades of research findings have accumulated, scientists now understand many of the molecular processes that cause our health to degenerate with chronological age. This was a crucial first step towards our goal of eradicating aging.
Uncovering factors involved in degenerative aging is critical because it’s difficult (but not impossible) to cure something if you don’t know what biological systems to target.
Smallpox and cholera are examples of diseases that were eradicated in certain parts of the world (by inoculation and sanitation) despite not knowing the underlying pathologic organism, or even if microorganisms caused disease.
With fundamental understandings of what causes us to adversely age, we can zero in on specific targets that can halt and in all probability reverse degenerative processes.
Immune Senescence: A Universal Killer
If one is fortunate to make it to advanced age in relatively good health, their most dangerous vulnerability is a deteriorating immune system.
A senescent immune system not only fails to protect against microbes and malignancies, but initiates a chronic inflammatory state that slowly destroys tissues.
It’s shocking to read of Olympic gold medal winners who perish as a result of a degenerative disorder in their older years. Johnny Weissmuller was an Olympic swimming champion who later appeared in movies as the original Tarzan. When I read an obituary as to how he died, it was another wakeup call that world-class physical abilities in youth mean little as we age past 65 years.
Ditto for Jack LaLanne who remained in remarkable shape into his 90s before succumbing to pneumonia, likely caused by a worn out immune system.
We know a lot about immune senescence today. To eradicate this plague that impacts most aging persons, we believe human studies must be expediently initiated. One area we need to assess is if plasma constituents from young donors will have a meaningful rejuvenating effect in elderly humans.
Once the concept of young plasma transfer is validated, we expect that more efficient means of utilizing this age reversal process will rapidly emerge. We have preliminary evidence of this already.
Each year, Life Extension Foundation provides about $10 million of funding to a broad spectrum of researchers seeking ways to eliminate aging and involuntary death.
More funding is required to support what are now several different projects that have significant potential to exert age-reversal effects in humans.
The costs of conducting these research initiatives is remarkably modest, yet at this time, no other charities are stepping up to provide support.
A company has been formed called Age Reversal Therapeutics, Inc., that aims to raise $25 million from accredited investors who appreciate the enormous value this research may yield, not just in financial terms, but by radically extending healthy human lifespans.
We expect the initial funding will cover 2-3 years of projected research and development expenses and the costs of acquiring and commercializing potentially innovative age-reversing therapeutic technologies. As far as whether there will be a market for these age-reversal technologies, we’ve had a steady stream of requests seeking personal access even before we initiate the first clinical trial.
Elderly Humans Clamor for Anti-Aging Drug
The front page of the April 24, 2016, edition of the Wall Street Journal described a virtual stampede of seniors seeking to enroll in a study to see if a single drug can postpone or reverse pathologic aging processes.
What these naïve masses are seeking access to is metformin. This drug was first recommended to our supporters in the March 1995 edition of Life Extension Magazine®.
The AMPK-activating properties of metformin (and other compounds) has generated consistent findings in the scientific literature as conferring protection against degenerative aging.
The headline news stories about metformin enabling humans to live to 120 years, however, are false. We at Life Extension believe this because our group has been using metformin to slow aging processes for decades.
While AMPK activators like metformin remain a priority to stave off premature degeneration, far more needs to be done to systemically reverse biological aging.
What this media frenzy shows is that the public is rebelling against the notion of degenerative aging and today’s limited lifespans. Rather than wait for senescence to slowly take its toll, elderly Americans are desperately trying to enter an FDA-approved clinical study where they may become experimental test subjects.
Just imagine what will happen when an age-reversal therapy is proven to work!
Year 2015: The Age-Reversal Renaissance Began
In 1449, Johannes Gutenberg invented the printing press. This was the most significant single advance mankind ever achieved. Printed books helped Europe to escape the suffocating ignorance of the Dark Ages.
Printed books enabled knowledge to be stored and conveyed from one generation to the next. Gutenberg’s invention helped transport humanity into what can be called a modern age of science and reason.
An even more significant human advance emerged in 2015. That year may go down in medical history as a pivotal shift in human thinking, i.e., a rebellion against natural aging.
Billionaires are writing checks to researchers for the purpose of finding ways to meaningfully extend healthy human lifespans. Multiple media reports beginning in 2015 describe scientific research initiatives being taken by wealthy individuals to make age reversal a reality in their own lifetime.
We view each of these news accounts with exhilaration. That’s because whoever discovers a validated method to reverse aging even to a small degree will likely open a floodgate of societal resources and consumer demand. The race to develop better rejuvenation technologies should result in human longevity research being prioritized above everything else.
In Renaissance Europe, the arrival of mechanical printing introduced the era of mass communication. This historic invention permanently altered the structure of society.
An array of biomedical advances is transforming human longevity potential into an era when upper-limit lifespans may not be predetermined by genetic limitations.
Do you think scientists who observe beneficial effects that occur before their eyes in the animal model will sit back while their own bodies suffer the ravages of aging? The answer is a resounding no!
An increasing number of enlightened individuals have embarked on aggressive experimental programs to meaningfully reverse aging in their own bodies.
Some of the world’s most prestigious scientists and a growing body of educated individuals are engaged in self-experimentation as a way to bypass the bureaucratic delays that hinder biomedical advances.
None of this self-experimentation would be occurring if we were not so close to an age reversal breakthrough.
How We Plan to Accelerate Progress
We think there are an enormous number of people that want to see human age reversal become a reality and invest in that goal. They have expressed interests in contributing towards meaningful research in the past, but I’ve rejected much of this because, up until recently, there was no reasonable clinical study we could initiate that might result in systemic age reversal.
Age Reversal Therapeutics, Inc., could have been set up as a company that solicited money from people of all economic classes. We chose instead to limit it only to those who would not deprive themselves of basic necessities for what must be viewed as a speculative endeavor.
In as much as age reversal is a common goal of thousands of people reading this article, I view it as a shared personal obligation for all to participate who are financially able to do so.
We expect there will be tangible benefits to being part of the initial investor group in Age Reversal Therapeutics, Inc., a company that seeks to identify, develop, and bring to market technologies to spare humans the horrific mental and physical consequences of degenerative aging.
If just 250 of the thousands of accredited persons reading this invest a mere $100,000, Age Reversal Therapeutics, Inc., will have raised the minimum it needs to initiate and complete several different projects that all have real-world potential to rapidly gain some degree of control over biological aging.
Healthy Longevity More Valuable Than Greater Wealth
Steve Jobs often talked about the foolishness of mankind as it relates to competing to be the wealthiest individual in a cemetery. Steve Jobs was not personally motivated to conquer aging, but he sure waged a long and costly battle against the pancreatic cancer that killed him at an early age (his widow is worth an estimated $17 billion).
Jobs touted novel accomplishments as being more important than adding more dollars to a wealthy person’s investment portfolio.
Those who participate in the unprecedented endeavor of reversing biological aging will indeed be contributing to potential accomplishments of momentous proportions. This includes young blood donors, older study subjects and investors/contributors who enable this research to happen.
The next page describes the accredited investor requirements to invest in these emerging technologies. I’ll conclude this article with a quote that is often attributed to Steve Jobs, but was written by Apple for a “think different” campaign they launched based on their arduous development of the iPhone:
Age Reversal Therapeutics, Inc.
For the first time in history, scientific advances have made it possible to achieve new levels of understanding in how the human body ages.
The costs to the economy of an aging population are significant. Imagine the savings that would occur if the population stayed healthier and youthfully fit decades longer!
A therapy to reverse biological aging would slash the massive costs associated with the current state of elderly care. If older people are rejuvenated, there would be huge reductions in societal costs for doctor visits, nursing home care, hospitalizations, surgeries and pharmaceuticals. Most importantly, the pain and suffering inflicted on individuals and their families would be reduced as people live healthier longer.
Today, many scientists around the world are focusing on various disorders, such as heart disease, cancer, diabetes and Alzheimer’s. Evidence suggests that a healthy diet and lifestyle can reduce the risk of some of these diseases, but the fact remains, the risk of all these diseases increases dramatically with aging.
If we could find a way to reverse the deleterious effects of aging on the body, disease rates would decline, along with the unsustainable costs associated with them.
The Company Vision
Age Reversal Therapeutics, Inc., is focused on developing and marketing effective interventions in aging, reversing debilitating age-related processes and diseases, and repairing accumulated damage associated with the elderly.
Although a “cure” for aging seems impossible, a cure for scurvy did not occur until sailors started bringing citrus fruits during long sea voyages. The discovery of vitamin C eliminated scurvy.
Aging is more complex and multifactorial. Our goal nonetheless is to bring forth the discoveries that can lead us toward elimination of aging as we know it.
Aging is our focus and the word Cure has special meaning:
- C (collaboration between scientists)
- U (understanding the mechanisms of aging)
- R (research funding)
- E (expedite development of promising therapies)
Age Reversal Therapeutics plans to develop interventions in-house, partner with other expert groups and provide late-stage funding to companies with validated age-reversal models that can be rapidly transitioned into the clinical arena.
To achieve these goals, Age Reversal Therapeutics plans to enter into partnerships and acquire licensing and marketing rights in select intellectual property in order to advance the company’s main mission.
Age Reversal Therapeutics, Inc. has obtained the rights to AgingPortfolio.org, a database for age-related studies. Numerous people enter this website monthly to access scientific data relating to published cancer and aging technical data, to find out which scientists are involved with various studies, and what funding has been provided to specific types of projects.
AgingPortfolio.org, is expected to become a key to advancing the science of anti-aging research at a faster pace.
Upon completion of a planned $25 million offering, Age Reversal Therapeutics, Inc., plans to advance funding to acquire rights specifically aimed at human age reversal. Success and future outcome predictions will be measurable with a results-ranking that will be designed to propel anti-aging science.
Age Reversal Therapeutics, Inc., also plans to participate in human age reversal research. The company’s founders are in discussion with scientific groups engaged in innovative research in studies involving immunology, stem cell biology, young plasma transfer, growth factor technology, and other disciplines. These projects may have a dramatic impact in reversing the deleterious impact of senescence. These projects will all require funding, management, development and commercialization that Age Reversal Therapeutics intends to provide.
The ultimate goal of Age Reversal Therapeutics, Inc., is to redefine aging as a lifetime of good health, without physical and mental decline.
The Immediate Goal
Age Reversal Therapeutics has identified several areas of research where significant rejuvenating effects have occurred in the laboratory model. These kinds of technologies need to be expeditiously verified in older human populations.
The founders of Age Reversal Therapeutics are appalled by the 6,000 Americans who perish every day from degenerative disorders.
In recognition of this catastrophic loss of human life and the horrific suffering that often precedes senescent-induced death, Age Reversal Therapeutics will seek to break down bureaucratic barriers that stifle advancement of therapies that may reverse biological aging and its associated morbidity and mortality.
The company’s plans are to obtain financial positions in technologies that in some cases require relatively small amounts of capital to transform the theoretical technology into probable clinical reality.
In the process of developing proprietary age reversal therapies, Age Reversal Therapeutics may earn substantial revenue. More importantly, transforming older people into younger biological beings is likely to spark a firestorm of interest across a huge swath of the economy. The optimal desired result will be a gargantuan transformation of financial and human resources that prioritize age-reversal research over other areas of the commercial spectrum.
An example of this transformative shift in priority is Professor Chris Toumazou, a distinguished electrical engineer whose inventions range from microchips in your cell phone to rapid-fire genomic sequencing. As it relates to how industry currently prioritizes the consumer electronics, Professor Toumazou states:
“…if you could apply just a fraction of that technology to healthcare, you could make major innovations.”
To prove his point, he has developed a tiny chip that maps your DNA from saliva analogous to what now requires a large laboratory.
Age Reversal Therapeutics wants to deliver a message to commercial interests that society doesn’t need better mobile phones or Band-Aid remedies for degenerative illness. The big money is likely to come from therapies that reverse pathological aging whereby the entire world becomes your customer.
Someone has to take the first step and deliver a validated age-reversal technology to the consumer marketplace. Age Reversal Therapeutics may be that company that breaks down the upper-limit barrier for healthy human longevity, and spurs others to develop even better technologies.
Altering Course of Medical History
Billions of dollars are now spent developing “drugs” that usually have only limited efficacy in mitigating a specific disease.
Once systemic age-reversal and its positive consequences are demonstrated in humans, a new paradigm of clinical medical practice is expected to emerge. This will happen as the scientific and investment community wakes up to the fact that finding meaningful treatments for aging may help minimize the most prevalent diseases impacting mankind.
Discoveries of this magnitude are expected to prompt widespread financial interest. This will likely occur as the investment community comes to the realization that the hottest area of consumer demand may be human age-reversal, and that substantial dollars might be earned by developing even better age reversal therapies.
According to Ray Kurzweil’s law of accelerating returns, once technical feasibility is demonstrated, the science often experiences exponential growth. This occurs as society prioritizes resource allocation in a way that rapidly improves the pioneering discovery.
In the case of Age Reversal Therapeutics, if the technology we have identified is able to prove the technical feasibility of age reversal, more commercial and charitable resources are expected to shift their focus to developing superior methods of preventing people from suffering and dying from old age.
Who Can Invest/Contribute to the Aging Cure Project?
Age Reversal Therapeutics is seeking funding via a private placement memorandum. The company can promote itself to the world, but can only accept funds from individuals who are defined as “accredited investors” under US Federal securities laws.
If enough accredited investors provide initial funding, then this age reversal research and business development project can move forward more rapidly.
If you are an accredited investor and have an interest in investing in Age Reversal Therapeutics, Inc., we encourage you to log on to the following website to review the offering memorandum: www.AgingCure.com
There is no guarantee of a financial return. If a profit is ultimately achieved, a share of profits that is not allocated to future growth and development would be available for distribution to investors in the company based on their ownership interest. Note, however, that amounts that are invested in the company are not tax-deductible charitable donations.
We believe that if there is a great enough interest in this offering, investments in the company may help advance the scientific research in a meaningful way that could very well extend the healthy lifespans of people who undergo treatments that use the technologies Age Reversal Therapeutics hopes to commercialize.
As a personal note, I know a lot of you have a sincere interest in helping to fund this project and believe it provides an exciting investment opportunity.
It is not possible to project what kind of income might be earned by this venture that seeks to rapidly develop human age-reversal technologies. The company’s primary focus will be to advance the science.
Please take a moment to read the disclaimers at the end of this article. This article should not be construed as an offer to invest. Any decisions to invest in Age Reversal Therapeutics, Inc., should solely be based on the offering memorandum that can be viewed at: www.AgingCure.com
THIS COMMUNICATION AND ANY INFORMATION HEREIN DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO PURCHASE SECURITIES TO ANY PERSON IN ANY JURISDICTION. THE SECURITIES TO BE ISSUED IN OUR RULE 506(C) OFFERING WILL NOT BE REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY OTHER LAW OR REGULATION, AND ONLY ACCREDITED INVESTORS, AS DEFINED IN 17 C.F.R. 230.501(A), MAY PURCHASE THEM.
NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT, WILL NOT BE ACCEPTED; NO SALES WILL BE MADE OR COMMITMENTS TO PURCHASE ACCEPTED UNTIL THE FINAL CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM AND ALL RELATED DOCUMENTS HAVE BEEN COMPLETED AND REVIEWED AND EXECUTED, AS APPLICABLE, BY ANY PROSPECTIVE INVESTOR. A PROSPECTIVE PURCHASER’S INDICATION OF INTEREST IS NON-BINDING. ANY INDICATION OF INTEREST BY A PROSPECTIVE PURCHASER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME.
IN THE EVENT THAT YOU ARE INTERESTED IN CONSIDERING AN INVESTMENT IN AGE REVERSAL THERAPEUTICS, INC., AND IN THE EVENT THAT WE DETERMINE TO OFFER YOU THE OPPORTUNITY TO PARTICIPATE IN SUCH INVESTMENT, YOU WILL BE PROVIDED WITH A CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM TOGETHER WITH APPROPRIATE EXHIBITS.
Safe Harbor Statement
This article contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results) and other factors included in Age Reversal Therapeutics, Inc. Private Placement Memorandum. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as “may,” “should,” “expect,” “anticipate,” “believe,” “estimate,” “intend,” “plan” and other similar expressions. Age Reversal Therapeutics, Inc.’s actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
If you have any questions on the scientific content of this article, please call a Life Extension® Wellness Specialist at 1-866-864-3027.